Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks
about
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virusInhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.Pharmacodynamics of (-)-beta-2',3'-dideoxy-3'-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans.Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.Dynamics of hepatitis B virus clearance in chimpanzees.Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil.Mathematical modeling of triphasic viral dynamics in patients with HBeAg-positive chronic hepatitis B showing response to 24-week clevudine therapy.2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivoSelective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocyclesEntecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.Animal models and the molecular biology of hepadnavirus infectionEmerging drugs for hepatitis B.Hepadnavirus Genome Replication and Persistence.Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytesHepatocyte turnover during resolution of a transient hepadnaviral infection.Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus.Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees.Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection.In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice.The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans.
P2860
Q28360714-8FA9F30C-F742-4578-AE6B-B981F2C64CE4Q33689987-883686AA-1A9E-4F72-978C-61DF0342B1A2Q33700651-52E56B4B-29F3-474E-AF06-D71A385C9FF6Q33834863-F30CFD9C-CC36-4A48-B536-FC238AE1535AQ33978482-9F6E7B5F-F032-4A44-8618-475C88AAC7E3Q34105204-C1106B5C-7D42-42E1-BF6F-3A5EE4AED30FQ34289969-D4707810-98F3-4762-B0B7-0D2C7669EA9EQ34298630-3CC0EE5D-CB68-4B9C-928F-7DF9BA3C6938Q34362568-339F135E-266A-418A-8E3B-7F0A956BC672Q34500227-7B21AF2C-F636-467D-A8AB-F4F68E85CDD2Q35122499-1A38BC96-C40C-4E9E-BFEC-0E5ADB3C8E37Q35139139-B7474BA3-CFF8-4853-AC9A-1D080BA2031BQ35166065-220660EE-E589-4B8D-8726-6DE78EF1620DQ35245221-E8C858DC-0924-4E98-A480-6ABD62D0F54EQ35359369-034F5ED7-6A50-445F-AFAE-5568A860FD5DQ35795545-E49F5813-C35D-4C9D-9D06-D7F0CB7AF161Q35825117-BB6721B9-7A4E-4101-8EFE-7B54F9430CF7Q35859684-5DE2B360-58E7-4B9B-9E59-94CBF52CC557Q36161444-D10E0EB4-591B-40C5-9703-787CE2FEBB42Q36548897-388E5471-9A49-4F47-9E58-AA29A2EDD380Q36605001-3C6FC92E-4970-4C07-9994-837011E1151EQ36667147-4F59BBA1-5DCD-4962-BB9C-7C7DF15192D6Q38636988-45FB442C-7BDB-466F-970A-027690A167F9Q39559680-9C510C08-D5DB-499E-AE5F-FE2E05302B18Q39784993-38115994-8087-49FE-8C0D-0DFAF2C7892CQ39880025-B08370DD-61BB-4808-B3B2-92BE0DD9CE6DQ47131005-A62996EC-4198-4FE1-8514-E94EC7FDE171
P2860
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Evidence that hepatocyte turno ...... of chronically infected ducks
@ast
Evidence that hepatocyte turno ...... of chronically infected ducks
@en
Evidence that hepatocyte turno ...... of chronically infected ducks
@nl
type
label
Evidence that hepatocyte turno ...... of chronically infected ducks
@ast
Evidence that hepatocyte turno ...... of chronically infected ducks
@en
Evidence that hepatocyte turno ...... of chronically infected ducks
@nl
prefLabel
Evidence that hepatocyte turno ...... of chronically infected ducks
@ast
Evidence that hepatocyte turno ...... of chronically infected ducks
@en
Evidence that hepatocyte turno ...... of chronically infected ducks
@nl
P2093
P2860
P1433
P1476
Evidence that hepatocyte turno ...... of chronically infected ducks
@en
P2093
C E Aldrich
D R Averett
J M Cullen
J Saputelli
P Schaffer
P2860
P304
P407
P577
1994-12-01T00:00:00Z